BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 21336636)

  • 1. Pathology of hereditary breast cancer.
    van der Groep P; van der Wall E; van Diest PJ
    Cell Oncol (Dordr); 2011 Apr; 34(2):71-88. PubMed ID: 21336636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management.
    Kleibl Z; Kristensen VN
    Breast; 2016 Aug; 28():136-44. PubMed ID: 27318168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary breast cancer: the era of new susceptibility genes.
    Apostolou P; Fostira F
    Biomed Res Int; 2013; 2013():747318. PubMed ID: 23586058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond BRCA: new hereditary breast cancer susceptibility genes.
    Economopoulou P; Dimitriadis G; Psyrri A
    Cancer Treat Rev; 2015 Jan; 41(1):1-8. PubMed ID: 25467110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
    Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
    Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.
    Yiannakopoulou E
    Cell Oncol (Dordr); 2014 Feb; 37(1):1-8. PubMed ID: 24306927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.
    Sato K; Koyasu M; Nomura S; Sato Y; Kita M; Ashihara Y; Adachi Y; Ohno S; Iwase T; Kitagawa D; Nakashima E; Yoshida R; Miki Y; Arai M
    Cancer Sci; 2017 Nov; 108(11):2287-2294. PubMed ID: 28796317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inherited mutations in breast cancer genes--risk and response.
    Shuen AY; Foulkes WD
    J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):3-15. PubMed ID: 21461995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary breast carcinomas pathologist's perspective].
    Vincent-Salomon A; Bataillon G; Djerroudi L
    Ann Pathol; 2020 Apr; 40(2):78-84. PubMed ID: 32241645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.
    Ren M; Orozco A; Shao K; Albanez A; Ortiz J; Cao B; Wang L; Barreda L; Alvarez CS; Garland L; Wu D; Chung CC; Wang J; Frone M; Ralon S; Argueta V; Orozco R; Gharzouzi E; Dean M
    Breast Cancer Res Treat; 2021 Sep; 189(2):533-539. PubMed ID: 34196900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years.
    Petridis C; Arora I; Shah V; Megalios A; Moss C; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ
    Breast Cancer Res; 2019 May; 21(1):58. PubMed ID: 31060593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    Scott CM; Joo JE; O'Callaghan N; Buchanan DD; Clendenning M; Giles GG; Hopper JL; Wong EM; Southey MC
    PLoS One; 2016; 11(11):e0165436. PubMed ID: 27902704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary Breast Cancer: BRCA Mutations and Beyond.
    Patel MM; Adrada BE
    Radiol Clin North Am; 2024 Jul; 62(4):627-642. PubMed ID: 38777539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to breast cancer.
    Bradbury AR; Olopade OI
    Rev Endocr Metab Disord; 2007 Sep; 8(3):255-67. PubMed ID: 17508290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next-Generation Sequencing Identifies
    Peker Eyüboğlu İ; Yenmiş G; Bingöl EN; Yüksel Ş; Tokat F; Özbek P; Güllü Amuran G; Yakıcıer C; Akkiprik M
    OMICS; 2020 Jan; 24(1):5-15. PubMed ID: 31851867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genes beyond BRCA1 and BRCA2 for hereditary breast cancer].
    Simon K; Geigl JB; Pristauz G
    Wien Med Wochenschr; 2010 Nov; 160(19-20):478-82. PubMed ID: 20890790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
    Lerner-Ellis J; Khalouei S; Sopik V; Narod SA
    Expert Rev Anticancer Ther; 2015; 15(11):1315-26. PubMed ID: 26523341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer predisposition syndromes.
    Hemel D; Domchek SM
    Hematol Oncol Clin North Am; 2010 Oct; 24(5):799-814. PubMed ID: 20816575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.